Journal article icon

Journal article

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

Abstract:

Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing cascade screening by genetic, as opposed to clinical methods. The incremental cost per life year saved was 14,397 euro for the cascade genetic compared with the cascade clinical approach. Genetic ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1093/eurheartj/ehq067

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Population Health
Thomson, K More by this author
Expand authors...
Journal:
European heart journal
Volume:
31
Issue:
8
Pages:
926-935
Publication date:
2010-04-05
DOI:
EISSN:
1522-9645
ISSN:
0195-668X
URN:
uuid:def93e02-5e5b-4c22-a6de-da6c7c38efe9
Source identifiers:
66507
Local pid:
pubs:66507

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP